XML 71 R55.htm IDEA: XBRL DOCUMENT v3.22.4

ACQUISITIONS - Unaudited Pro Forma Summary of Operations (Details) - BioDelivery Sciences International, Inc - USD ($) $ in Thousands		12 Months Ended
	Jan. 01, 2021	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Total revenues		$ 493,284	$ 443,571
Net income		$ 8,674	$ 15,015
Acquisition costs	$ 14,718
Employee severance related expense	$ 8,008

X

- Definition

Amount of acquisition related costs.

+ References

No definition available.

+ Details

Name:	coll_BusinessAcquisitionProFormaAcquisitionRelatedCosts
Namespace Prefix:	coll_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of employee severance related expense.

+ References

No definition available.

+ Details

Name:	coll_BusinessAcquisitionProFormaEmployeeSeveranceRelatedExpense
Namespace Prefix:	coll_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=coll_BiodeliverySciencesInternationalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: